Abstract
The continued significance of human embryonic stem cell research and recent advances in human somatic cell nuclear transfer and human gamete and embryo gene editing have given rise to renewed debates on the donation and use of human embryos and oocytes for research, therapies, and commercial applications. Sociological studies of cell and tissue donation have also indicated that the ethical procedures and social and moral values that surround the donation and use of human reproductive tissues for research do often differ across countries. This chapter addresses the donation of human embryos for human embryonic stem cell research in China. The chapter is based on interviews with 15 IVF clinicians , 15 stem cell researchers, and 15 IVF patients who were asked to donate their embryos for hESC research. Part I focuses on the role and enactment of informed consent procedures. A question that I ask in this respect is what ideas are communicated to potential embryo donors, so that the donation of their spare embryos for hESC research appears reasonable and justifiable? Based on interview data I will illustrate a variety of rhetorical practices and strategies that underpin informed consent procedures. These range from the responsible facilitation of informed choice that emphasizes patient autonomy and the right to refuse donation to more problematic rhetorical practices that involve the provision of false facts and patient deception. Part II discusses these findings in light of the regulatory context in which human embryonic stem cells are produced, banked, and distributed in China. To illustrate the specific effects of this regulatory system, I will draw on a comparison with the regulatory situation in the UK. The chapter concludes that there is often a significant gap between the ways in which the value and use of donated embryos is described to patients and the actual forms of value that these tissues gain in the context of research, distribution, and commercial use. With the renewed importance of human gametes and embryos for human genome editing, these findings indicate that there is the need for more, critical in-depth research into actual donation practices of gametes and embryos and into the needs and perceptions of human tissue donors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Corrigan O (2003) Empty Ethics: the problem with informed consent. Sociology of Health and Illness 25(3):768–792
Dickenson D (2006) The lady vanishes: what’s missing from the stem cell debate. Biotech Inq 3:43–54
Franklin S (2006) The IVF-Stem cell Interface. International Journal of Surgery 4(4):86–90
Rosemann A (2010) The IVF-stem cell interface in China: ontologies, value-conceptions and donation practices of ‘Chinese’ forms of unborn human life. In: Doering O (ed) Life sciences in translation: a Sino-European dialogue on ethical governance of the life sciences. BIONET, London, 168–178
Rosemann A (2011) Modalities of value, exchange, solidarity: exploring the social life of stem cells in China. New Genet Soc 30(2):181–192
Rosemann A, Luo HY (under review) Attitudes and perceptions on hESC research and embryo donation among IVF patients, hESC researchers and students in China. Journal of Bioethical Inquiry
Sleeboom-Faulkner M (2014) Global morality and life science practices in Asia: assemblages of life. Palgrave MacMillan, London
Stephens N, Atkinson P, Glasner P (2008) The UK stem cell bank: securing the past, validating the present, protecting the future. Science as Culture 17(1):43–56
Svendsen MN, Koch L (2008) Unpacking the “spare embryo”: facilitating stem cell research in a moral landscape. Social Studies of Science 38(1):93–110
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145–1147
Waldby C, Mitchell R (2006) Tissue economies: blood, organs, and cell lines in late capitalism. Duke University Press, Durham and London
Warrell D (2009) Cure committee report: China–UK research ethics. UK Medical Research Council. http://www.mrc.ac.uk/Utillities/Documentrecord/index.htm?d=MRC006303. Retrieved 24 Feb 2016
Acknowledgments
This article has benefited from research support provided by the European Research Council (ERC, 283219) and the Economic and Social Science Research Council (ESRC, ES/I018107/1). Due to ethical concerns, supporting data cannot be made openly available.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Rosemann, A. (2017). Contested Tissues: The Donation of Oocytes and Embryos in the IVF-Stem Cell Interface in China. In: Pham, P., Rosemann, A. (eds) Safety, Ethics and Regulations. Stem Cells in Clinical Applications. Springer, Cham. https://doi.org/10.1007/978-3-319-59165-0_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-59165-0_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-59164-3
Online ISBN: 978-3-319-59165-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)